Annovis Bio Corporation (ANVS) Price Chart

ANVS (Annovis Bio Corporation) - company brandmark

The linear price action on the Annovis Bio, Inc. (ANVS) chart is tied to the results of tests for dementia and tremor treatments, where the key 0.76 metric is the efficiency of brain clearance. The US R&D center is developing agents to combat neuron decay, leveraging an innovative protein blocking method. Strong software patent protection shields the biotech business from market pressure while large-scale research on new drugs continues.

Annovis Bio, Inc. - ANVS Price Chart (period 07/04/2022 - 11/17/2026)

Annovis Bio Corp (ANVS) - metric breakdowns and financial figures

Analysis of all company metrics:annovisbio.com ANVS
Signature product of Annovis Bio Inc

The market value of Annovis Bio, Inc. (ANVS) shares captures the current balance of supply and demand, reflecting investors' aggregate valuation of future cash flows and the business's fundamental value. When analyzing the price trajectory of Annovis Bio, Inc. (ANVS), it is essential to consider that current quotes are critically dependent on clinical trial outcomes, where any data indicating the inefficiency of neurodegenerative disease therapies could instantaneously wipe out the company's capitalization.

Analysis of competing companies

Stock Price BIIB|Neurocrine Biosciences, Inc. - Share Price|Stock Price RGC (Regencell Bioscience Ltd)|AXSM: Share Price|ACADIA Corp - Stock Price|XENE (Xenon Pharmaceuticals) - Share Price|VKTX (Viking Pharma) - Stock Quotes|Share Price SUPN|Price Chart Catalyst Pharmaceuticals|Share Price DNLI (Denali Therapeutics Inc)|Stock Price HRMY|BHVN - Market Price|amylyx.com - Stock Quotes|Stock Price Trevi Therapeutics Inc TRVI|PRAX - Price Chart|Price Performance Chart AVXL (Anavex Life Sciences Corp)|CeriBell Inc (CBLL) - Price Chart|Market Price Prothena Corp (PRTA)|ALEC (Alector Therapeutics) - Stock Price|Stock Price Annexon Biosciences|Price Chart Omeros Corp (OMER)|NGNE - Market Price|AC Immune - Stock Quotes|Voyager Therapeutics (VYGR) - Market Price|NMRA - Price Chart|SCLX: Price Chart|TVGN: Stock Price|Alpha Cognition (ACOG) - Stock Price|Stock Quotes CGTX|Stock Price Inhibikase Therapeutics|Stock Price SAVA|Market Chart Assertio Holdings|Stock Price COYA (Coya Therapeutics)|VTGN: Share Price|OVID - Price Chart|Price Performance Chart ABOS (Acumen Pharmaceuticals)|CRVO: Stock Price|ATHE: Price|CLNN (clene.com) - Stock Price|pepgen.com (PEPG) - Market Chart|Price Chart Jupiter Neurosciences Inc (JUNS)|RLMD (Relmada Therapeutics) - Price Performance Chart|Stock Price GRCE (Grace Therapeutics)|Firefly Neuroscience, Inc. (AIFF) - Market Price|Klotho Neurosciences - Stock Price|Market Price NeuroSense Therapeutics Ltd.|RVPH: Stock Price|MetaVia, Inc. (MTVA) - Stock Price|Stock Quotes NRXS|Helius Medical (HSDT) - Market Chart|Price Chart passagebio.com (PASG)|NEUP - Market Price|Price Chart Minerva Neurosciences, Inc. NERV|Market Chart Athira Pharma, Inc. (ATHA)|addextherapeutics.com - Stock Price|Market Chart alzamend.com ALZN|CYCN: Stock Price|PTIX: Price|Price Chart Pasithea Therapeutics Corp.|Stock Price cortigent.com|Stock Quotes ATXI (Avenue Therapeutics, Inc)|Stock Price Brainstorm Cell Therapeutics Inc. (BCLI)|Stock Price CARA (Cara Therapeutics Inc)|Market Chart Chromocell Therapeutics Corporation (CHRO)|Eliem - Stock Price|Market Chart intracellulartherapies.com ITCI|Longboard Pharmaceuticals Inc (LBPH) - Price Chart|Marinus Pharmaceuticals Inc - Price Performance Chart|Price Chart NKGen|Price Chart NRBO|Price Chart Sage Therapeutics (SAGE)|Market Chart Synaptogenix|Stock Price TRVN (trevena.com)|Vigil Neuro - Price Chart|Anew Medical Inc. - Stock Price|Market Price Cerevel